Stay updated on Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial
Sign up to get notified when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.

Latest updates to the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page
- Check4 days agoChange DetectedA site-wide notice about the NIH terminology transition appears above the 403 error page, and the displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe ClinicalTrials.gov error page’s footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check32 days agoChange DetectedAccess to the study record currently displays a 403 Forbidden error page with a minimal header, replacing the usual study details and navigation. The added 403 content indicates the page is blocked and the previously visible content is no longer accessible.SummaryDifference16%

- Check39 days agoChange DetectedThe page now shows Revision: v3.7.0, replacing the previous Revision: v3.6.6, indicating a newer site release. This update changes only the version label and does not modify any study details or visible content.SummaryDifference0.1%

- Check46 days agoChange DetectedNo additions or deletions are listed in the changes data. The Study Details page content remains unchanged based on the provided information.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page footer updated from Revision: v3.6.5 to Revision: v3.6.6, indicating a small software/UI revision. The change does not modify study details or how information is presented to users.SummaryDifference0.2%

Stay in the know with updates to Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.